Ophthalmic Laser Company Lumenis Receives FDA 510(k) Approval

Lumenis, an Israel-based medical laser company for ophthalmic and surgical applications, received FDA 510(k) clearance for the ResurFX, a fractional non-ablative laser module.

Advertisement
Heather Linder

The ResurFX is part of Lumenis’ M22 platform. It uses a 1565 nm fiber laser and CoolScan scanner which create a homogeneous pattern of coagulation columns.

More Articles on Ophthalmology:
UC Irvine to Open $39M Gavin Herbert Eye Institute
7 Statistics on Rewarding Aspects of Ophthalmology Practice
Saratoga Vitreo-Retina Ophthalmology Celebrates 6k Patient Milestone

Patient perception vs. reality: The role of accreditation in ASC safety

Recommended Whitepaper

Advertisement

Next Up in Ophthalmology

  • Montana physician practice acquired 

    Southlake, Texas-based Retina Consultants of America has acquired Montana Retina Consultants, according to a Feb. 5 news release.  Bozeman-based Montana…

    By: Patsy Newitt

  • Louisiana ophthalmology practice acquired 

    Vision Innovation Partners acquired Ophthalmic Associates of Alexandria (Va.), according to a Feb. 2 press release. Founded in 2010, Ophthalmic…

    By: Patsy Newitt

  • American Board of Ophthalmology names CEO

    The American Board of Ophthalmology has appointed Steven Gedde, MD, as its next CEO.  Dr. Gedde is an ophthalmologist and…

    By: Cameron Cortigiano
Advertisement

Comments are closed.